Glass vials are pictured inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

An employee shows a glass ampoule inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

A closeup shows an ampoule making machine inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

An employee examines glass vials inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

An employee packs glass vials inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

An employee mans a vial making machine inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

An employee uses a digital Vernier caliper to measure a vial inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

An employee fills glass tubes in a vial making machine inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Jambusar in the western state of Gujarat, India, December 1, 2020. Picture taken December 1, 2020. REUTERS/Amit Dave

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering gestures as he views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson poses for a photograph with a vial of the AstraZeneca/Oxford University COVID-19 candidate vaccine, known as AZD1222, at Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson poses for a photograph with a vial of the AstraZeneca/Oxford University COVID-19 candidate vaccine, known as AZD1222, at Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson poses for a photograph with a vial of the AstraZeneca/Oxford University COVID-19 candidate vaccine, known as AZD1222, at Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering, poses for a photograph with a vial as he views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering reacts as he views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering reacts as he views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

Britain's Prime Minister Boris Johnson, wearing a hair net and face covering reacts as he views the last minute quality testing of the 'fill and finish' stage of the manufacturing process of COVID-19 vaccines, during his visit to Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. Paul Ellis/Pool via REUTERS

A man tries out a rowing machine in a showroom of U.S. gym equipment manufacturer WaterRower in Munich, Germany, November 26, 2020. Picture taken November 26, 2020. REUTERS/Andreas Gebert

A man tries out a rowing machine in a showroom of U.S. gym equipment manufacturer WaterRower in Munich, Germany, November 26, 2020. Picture taken November 26, 2020. REUTERS/Andreas Gebert

A man tries out a rowing machine in a showroom of U.S. gym equipment manufacturer WaterRower in Munich, Germany, November 26, 2020. Picture taken November 26, 2020. REUTERS/Andreas Gebert

A man tries out exercising equipment in a showroom of U.S. gym equipment manufacturer WaterRower in Munich, Germany, November 26, 2020. Picture taken November 26, 2020. REUTERS/Andreas Gebert

A man tries out weights made from leather in a showroom of U.S. gym equipment manufacturer WaterRower in Munich, Germany, November 26, 2020. Picture taken November 26, 2020. REUTERS/Andreas Gebert

An employee works at the Kirsh Foundry in Beaver Dam, Wisconsin, U.S., April 12, 2018. Picture taken April 12, 2018. REUTERS/Timothy Aeppel

An exterior view of the Kirsh Foundry in Beaver Dam, Wisconsin, U.S., April 12, 2018. Picture taken April 12, 2018. REUTERS/Timothy Aeppel

An employee works at the Kirsh Foundry in Beaver Dam, Wisconsin, U.S., April 12, 2018. Picture taken April 12, 2018. REUTERS/Timothy Aeppel

A speed limit sign is seen beside a city sign for Economy, Indiana, U.S., November 10, 2020. Picture taken November 10, 2020. REUTERS/Timothy Aeppel

A worker pours hot metal at the Kirsh Foundry in Beaver Dam, Wisconsin, U.S., April 12, 2018. Picture taken April 12, 2018. REUTERS/Timothy Aeppel

U.S. Senator Jerry Moran, R-KS, presides over a Senate Commerce, Science, and Transportation Committee on the American manufacturing industry?s response to COVID-19 pandemic, on Capitol Hill, Washington, U.S. November 17, 2020. Saul Loeb/Pool via REUTERS

U.S. Senator Jerry Moran, R-KS, presides over a Senate Commerce, Science, and Transportation Committee on the American manufacturing industry?s response to COVID-19 pandemic, on Capitol Hill, Washington, U.S. November 17, 2020. Saul Loeb/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Saul Loeb/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Saul Loeb/Pool via REUTERS

Senator Jerry Moran, R-KS, leaves a Senate Commerce, Science, and Transportation Committee on the American manufacturing industry?s response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Senator Jerry Moran, R-KS, looks on during a Senate Commerce, Science, and Transportation Committee on the American manufacturing industry?s response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

Ravi Bulusu, Founder, MolMas, testifies during a Senate Commerce, Science, and Transportation Committee hearing on the American manufacturing industry's response to COVID-19, on Capitol Hill, Washington, U.S. November 17, 2020. Graeme Jennings/Pool via REUTERS

The logo of Spanish pharmaceutical firm Rovi, in charge of the "fill and finish" final stage of manufacturing for Moderna's COVID-19 vaccine, is seen outside their lab in San Sebastian de los Reyes, Spain on November 17, 2020. REUTERS/Marco Trujillo

The logo of Spanish pharmaceutical firm Rovi, in charge of the "fill and finish" final stage of manufacturing for Moderna's COVID-19 vaccine, is seen outside their lab in San Sebastian de los Reyes, Spain on November 17, 2020. REUTERS/Marco Trujillo

Hungarian biologists Alexandra Torok and Noemi Lukacs check the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Hungarian biologist, Noemi Lukacs shows test tubes with antibodies, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Hungarian biologist, Noemi Lukacs shows a test tube with antibodies, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo

Logo of Swiss domestic appliance manufacturer V-Zug AG is seen at a branch office in Zurich, Switzerland November 12, 2020. REUTERS/Arnd Wiegmann

Logo of Swiss domestic appliance manufacturer V-Zug AG is seen at a branch office in Zurich, Switzerland November 12, 2020. REUTERS/Arnd Wiegmann

A worker walks at Xunxi factory, which is an affiliate of Chinese e-commerce giant Alibaba, during a media tour, in Hangzhou, Zhejiang province, China November 10, 2020. REUTERS/Aly Song

A worker works at Xunxi factory, which is an affiliate of Chinese e-commerce giant Alibaba, during a media tour, in Hangzhou, Zhejiang province, China November 10, 2020. REUTERS/Aly Song

A worker works at Xunxi factory, which is an affiliate of Chinese e-commerce giant Alibaba, during a media tour, in Hangzhou, Zhejiang province, China November 10, 2020. REUTERS/Aly Song

Taiwan President Tsai Ing-wen announces the appointment of Morris Chang, the founder of the Taiwan Semiconductor Manufacturing Company (TSMC), to attend this year's APEC summit on her behalf during a news conference in Taipei, Taiwan, November 10, 2020. REUTERS/Ann Wang